2 more embarrassingly cheap dividend stocks I would buy

Here’s why Andy Ross thinks these two FTSE 100 (INDEXFTSE: UKX) companies could provide investors with impressive returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I recently looked at two dividend stocks that were showing a great combination of a low P/E and high dividend yield. Carrying on this research, it’s clear that they are far from being the only ones, as I’ve come across two other shares in the FTSE 100 that also have this potential winning combination.

Show me the money

Let me explain why I think the combination is usually such a good one. The low P/E means an investor gets the shares cheap, so there’s greater potential for future growth, and the high dividend means investors get income that can be used to live on, or even better, to buy more shares. The latter approach is known as compound investing and is a recognised way of building wealth.

Falling off a cliff?

But shares are cheap for a reason so let’s address the biggest issue facing my first pick, pharmaceutical company GlaxoSmithKline (LSE: GSK). It is the problem of drug patent expirations. On that front, progress is being made with 13 drugs currently going through trials at phase III, which is a late stage of development. In recent years there had been concern that pharma companies like GSK were facing a patent cliff, but the development of new blockbuster drugs could ease the pain.

The latest news from the company also provides some reassurance as the pivotal phase III CAPTAIN study of once-daily single inhaler triple therapy Trelegy Ellipta met its primary endpoint, a positive step on the path to getting onto pharmacy shelves. In April GSK also got approval for a two-drug medication in the US for the treatment of HIV. 

The signs are positive for the firm with Q1 turnover up 5% to £7.7bn, and operating profit up 10% to £1.4bn. Investors looking at the shares now would get them on a P/E of less than 13 which indicates good value, and on top of that, GSK offers great income potential as the dividend yield is a meaty 5.3%.

No crash landing

Airline easyJet (LSE: EZJ) is even cheaper than GSK, offering a larger yield of 5.6% and lower P/E ratio (under nine). How so? The latest trading update again flagged concerns around Brexit, but overall the numbers showed an airline that is doing well and has been preparing extensively for our EU exit. 

Although the company may be more cautious in its outlook, Q1 is likely to see good growth. In its April update, the airline stated that revenue is expected to grow by 7.3% with seat capacity growing by 14.5%, although costs are rising more quickly, which could hit future profits. FTSE 100 rival International Consolidated Airlines, which owns British Airways, has seen profits plunge, suggesting either that easyJet is doing better or that we can also expect it (in the short term) to be hit by issues of overcapacity and cost headwinds.

The concerns look to be factored into the price however, and I think easyJet is the better of these listed airline operators. Yes, there may be issues facing the industry, but I expect over the longer term that easyJet will be able to fly higher with its cheap prices, strong brand and range of popular destinations. Interim results out tomorrow will show more clearly the direction of travel. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »